{"transactions":[{"id":748055,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2026-06-05T20:42:00.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":30975,"price":2.9401,"value":91069.5975,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $3.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."}],"balance_after":762025,"source":{"system":"sec-edgar","filing":"0001746808-26-000004","document":"form4-06052026_080654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000174680826000004/form4-06052026_080654.xml","form_type":"4"}},{"id":748054,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2026-06-05T20:42:00.000Z","date":"2026-06-04","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":3.1638,"value":632760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.07 to $3.345, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."}],"balance_after":793000,"source":{"system":"sec-edgar","filing":"0001746808-26-000004","document":"form4-06052026_080654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000174680826000004/form4-06052026_080654.xml","form_type":"4"}},{"id":942162,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-09T22:52:35.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":1150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":1150000,"derivative":{"exercise_price":1.31,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":1150000},"source":{"system":"sec-edgar","filing":"0001746808-26-000002","document":"form4-01092026_100131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000174680826000002/form4-01092026_100131.xml","form_type":"4"}},{"id":1049827,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-03T21:04:34.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":1025000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":1025000,"derivative":{"exercise_price":1.74,"expiration_date":"2035-08-28","underlying":"Common Stock","underlying_shares":1025000},"source":{"system":"sec-edgar","filing":"0001415889-25-023570","document":"form4-09032025_090928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925023570/form4-09032025_090928.xml","form_type":"4"}},{"id":1260122,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":175000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":1.06,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260121,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":175000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":0.785,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260120,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":3.86,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260119,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":125000,"derivative":{"exercise_price":0.785,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260118,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":2.8,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":42534},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260117,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":42534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":42534,"derivative":{"exercise_price":0.785,"expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":42534},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260116,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":5.03,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260115,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":100000,"derivative":{"exercise_price":0.785,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260114,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":52500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":4.75,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260113,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":52500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":52500,"derivative":{"exercise_price":0.785,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260112,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":7.16,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1260111,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:43:42.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":90000,"derivative":{"exercise_price":0.785,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-004762","document":"form4-02202025_120238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925004762/form4-02202025_120238.xml","form_type":"4"}},{"id":1310821,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-06T23:06:08.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":0.77,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-25-000838","document":"form4-01062025_110104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000141588925000838/form4-01062025_110104.xml","form_type":"4"}},{"id":1692748,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-03T23:17:47.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":0.73,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-24-000523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919124000523/doc4.xml","form_type":"4"}},{"id":2028572,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-07T23:49:17.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":125000,"derivative":{"exercise_price":3.86,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-007679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919123007679/doc4.xml","form_type":"4"}},{"id":2068088,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-04T23:53:34.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":175000,"derivative":{"exercise_price":1.06,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-001369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919123001369/doc4.xml","form_type":"4"}},{"id":2546475,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-08T01:02:35.000Z","date":"2021-10-06","kind":"exercise","acquired":false,"shares":2467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":2.8,"exercise_date":"2021-05-19","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":2467},"source":{"system":"sec-edgar","filing":"0001209191-21-060004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121060004/doc4.xml","form_type":"4"}},{"id":2546474,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-08T01:02:35.000Z","date":"2021-10-06","kind":"exercise","acquired":false,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":4.75,"exercise_date":"2020-12-10","expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001209191-21-060004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121060004/doc4.xml","form_type":"4"}},{"id":2546473,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T01:02:35.000Z","date":"2021-10-06","kind":"sale","acquired":false,"shares":2467,"price":7.0076,"value":17287.7492,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on March 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-21-060004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121060004/doc4.xml","form_type":"4"}},{"id":2546472,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T01:02:35.000Z","date":"2021-10-06","kind":"exercise","acquired":true,"shares":2467,"price":2.8,"value":6907.6,"ownership":{"direct":true},"balance_after":995467,"source":{"system":"sec-edgar","filing":"0001209191-21-060004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121060004/doc4.xml","form_type":"4"}},{"id":2546471,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T01:02:35.000Z","date":"2021-10-06","kind":"sale","acquired":false,"shares":5625,"price":7.0077,"value":39418.3125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on March 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-21-060004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121060004/doc4.xml","form_type":"4"}},{"id":2546470,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T01:02:35.000Z","date":"2021-10-06","kind":"exercise","acquired":true,"shares":5625,"price":4.75,"value":26718.75,"ownership":{"direct":true},"balance_after":998625,"source":{"system":"sec-edgar","filing":"0001209191-21-060004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121060004/doc4.xml","form_type":"4"}},{"id":2675833,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-08","kind":"exercise","acquired":false,"shares":10945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, representing a right to purchase a total of 31,875 shares, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":4.75,"exercise_date":"2019-12-10","expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":10945},"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675832,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":13900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, representing a right to purchase a total of 31,875 shares, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, and in 36 equal monthly installments thereafter."}],"balance_after":10945,"derivative":{"exercise_price":4.75,"exercise_date":"2019-12-10","expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":13900},"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675831,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":8490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing a right to purchase a total of 14,999 shares, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":2.8,"exercise_date":"2021-05-19","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":8490},"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675830,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-04","kind":"exercise","acquired":false,"shares":7030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, representing a right to purchase a total of 31,875 shares, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, and in 36 equal monthly installments thereafter."}],"balance_after":24845,"derivative":{"exercise_price":4.75,"exercise_date":"2019-12-10","expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":7030},"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675829,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-04","kind":"exercise","acquired":false,"shares":6509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing a right to purchase a total of 14,999 shares, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, and in 36 equal monthly installments thereafter."}],"balance_after":8490,"derivative":{"exercise_price":2.8,"exercise_date":"2021-05-19","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":6509},"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675828,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":10495,"price":7.1763,"value":75315.2685,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 to $7.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675827,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-08","kind":"exercise","acquired":true,"shares":10495,"price":4.75,"value":49851.25,"ownership":{"direct":true},"balance_after":1003495,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675826,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":13900,"price":7.1413,"value":99264.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675825,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":13900,"price":4.75,"value":66025.0,"ownership":{"direct":true},"balance_after":1006900,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675824,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":8490,"price":7.0842,"value":60144.858,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675823,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":8490,"price":2.8,"value":23772.0,"ownership":{"direct":true},"balance_after":1001490,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675822,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":7030,"price":7.005,"value":49245.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.04, inclusive. The reporting\nperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full\ninformation regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675821,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-04","kind":"exercise","acquired":true,"shares":7030,"price":4.75,"value":33392.5,"ownership":{"direct":true},"balance_after":1000030,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675820,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":6509,"price":7.0058,"value":45600.7522,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.04, inclusive. The reporting\nperson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full\ninformation regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2675819,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-09T10:03:33.000Z","date":"2021-06-04","kind":"exercise","acquired":true,"shares":6509,"price":2.8,"value":18225.2,"ownership":{"direct":true},"balance_after":999509,"source":{"system":"sec-edgar","filing":"0001209191-21-039081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121039081/doc4.xml","form_type":"4"}},{"id":2916106,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T22:00:15.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":100000,"derivative":{"exercise_price":5.03,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-002168","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919121002168/doc4.xml","form_type":"4"}},{"id":2928921,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-30T22:00:07.000Z","date":"2020-12-28","kind":"sale","acquired":false,"shares":25000,"price":4.5218,"value":113045.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $4.5218. The range of sale prices on the transaction date was $4.34 to $4.76 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":993000,"source":{"system":"sec-edgar","filing":"0001209191-20-065537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919120065537/doc4.xml","form_type":"4"}},{"id":3019919,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-30T21:00:09.000Z","date":"2020-09-28","kind":"sale","acquired":false,"shares":25000,"price":5.6158,"value":140395.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.6158. The range of sale prices on the transaction date was $5.51 to $5.82 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":1018000,"source":{"system":"sec-edgar","filing":"0001209191-20-052467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919120052467/doc4.xml","form_type":"4"}},{"id":3082824,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-15T21:00:15.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":250000,"price":8.1339,"value":2033475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $8.1339. The range of sale prices on the transaction date was $7.50 to $9.05 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."}],"balance_after":1043000,"source":{"system":"sec-edgar","filing":"0001209191-20-042499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919120042499/doc4.xml","form_type":"4"}},{"id":3139321,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-21T20:30:25.000Z","date":"2020-05-19","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":60000,"derivative":{"exercise_price":2.8,"expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-031278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919120031278/doc4.xml","form_type":"4"}},{"id":3343787,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-12T23:04:24.000Z","date":"2019-12-10","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":90000,"derivative":{"exercise_price":4.75,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-19-060270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919119060270/doc4.xml","form_type":"4"}},{"id":3653924,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":40948,"kind":"person","name":"Connelly Stephen","position":1,"cik":"0001746808","reported_name":"Connelly Stephen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-15T23:22:34.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":90000,"derivative":{"exercise_price":7.16,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-19-010767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746808/000120919119010767/doc4.xml","form_type":"4"}}]}